Adenocarcinoma

Adenocarcinoma is a cancer that begins in glandular cells, the cells that produce mucus and other fluids in the linings of internal organs. In the context of asbestos disease, it most often refers to a subtype of non-small cell lung cancer (NSCLC) that typically arises in the outer (peripheral) regions of the lungs. It is the most commonly diagnosed type of lung cancer and can be linked to asbestos exposure when an adequate occupational history, sufficient latency, and supporting medical evidence are present.

Origin

From the Greek aden (gland) and karkinos (crab), the latter used since antiquity to describe tumors because of their crab-like invasion of surrounding tissue. The modern term came into medical use in the 19th century to distinguish glandular cancers from other carcinomas such as squamous cell carcinoma.

Significance in Asbestos Context

Lung adenocarcinoma is one of the cancers most frequently linked to asbestos exposure and is a qualifying diagnosis in nearly every asbestos bankruptcy trust and in civil lawsuits. Because it grows in the outer lung, it often produces no early symptoms, making low-dose CT screening particularly important if you have a significant exposure history. Under the Helsinki Criteria and similar consensus guidelines, asbestos is recognized as a cause of lung adenocarcinoma when there is sufficient cumulative exposure (often expressed as roughly 25 fiber-years) and a latency of at least 10 years from first exposure; importantly, asbestosis does not need to be present for asbestos to be accepted as a cause. Defense experts frequently argue that adenocarcinoma is a "smoker's cancer" and try to attribute it solely to tobacco, but the synergistic interaction between asbestos and smoking, which can multiply lung cancer risk many times over, is well established, and asbestos need only be shown as a substantial contributing factor, not the sole cause. Pathological evidence such as asbestos bodies or fiber burden analysis in lung tissue, when available, can strongly support the asbestos connection.

Example Sentence

After Maria's biopsy confirmed adenocarcinoma in the lower lobe of her left lung, her pulmonologist documented her 22-year history of working with asbestos insulation, which became central evidence in her trust fund claim.

Related Terms

Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma, Helsinki Criteria, Fiber-Year, Synergistic Effect, Fiber Burden Analysis, Latency Period

Notes

• Ask your oncologist or pulmonologist to record a detailed asbestos exposure history in your medical chart, approximate dates, employers, job sites, duties, and specific products. This contemporaneous documentation is often the foundation of both lawsuits and trust claims.
• If lung tissue was removed during biopsy or surgery, ask the hospital pathology department whether the tissue blocks and slides have been preserved. Archived tissue can later be used for asbestos body counts or fiber burden analysis, which can directly rebut a "smoking alone" defense.
• A smoking history does not disqualify you from filing. Tell your attorney about it honestly; the synergistic relationship between asbestos and tobacco is accepted by courts, and asbestos only needs to be a substantial contributing factor.
• Ask your doctor whether you qualify for annual low-dose CT lung cancer screening based on your age, smoking history, and asbestos exposure. Early-stage adenocarcinoma is far more treatable.
• Statutes of limitations for asbestos lung cancer claims are short, often one or two years from diagnosis or from when the asbestos link was or should have been known. Contact an asbestos-experienced attorney promptly after diagnosis.
• Preserve pathology reports, imaging (CT, PET), operative notes, employment and union records, Social Security earnings statements, and any product identification information. These records are essential for both litigation and trust claims.
• Lung adenocarcinoma is the most established asbestos-related adenocarcinoma, but IARC also recognizes associations with cancers of the larynx and ovary, and possibly the pharynx, stomach, and colorectum. If you have one of these diagnoses with a strong exposure history, ask your attorney whether a claim may still be viable.